生物医药产业的“成都处方”：当企业说出产品“入院难” 医院负责人当场接话

Core Insights - The "Jin Jie You Cu" event in Chengdu facilitates direct communication between enterprises and government departments, addressing challenges faced by the biopharmaceutical industry [1][6] - Chengdu's biopharmaceutical industry is experiencing rapid growth, with a market size exceeding 400 billion yuan and a strong focus on innovation and collaboration [7][8] Group 1: Event Overview - The "Jin Jie You Cu" event gathered over 30 enterprises, government officials, and industry experts to discuss challenges and solutions in the biopharmaceutical sector [1] - Companies like Kelun Pharmaceutical and Microchip Biotech highlighted the importance of direct dialogue with government representatives to resolve issues [1][6] Group 2: Company Challenges - Chengdu-based companies face difficulties in hospital admissions for their innovative products, with a call for policies to prioritize local medical devices [3][6] - Microchip Biotech emphasized the need for better access to clinical resources and support for innovative drug development [3][6] Group 3: Government Responses - Government departments responded to company concerns by outlining support for new drug research and addressing regulatory challenges [6] - The Chengdu Municipal Science and Technology Bureau is focusing on supporting projects that align with enterprise needs, particularly in high-end medical equipment [6] Group 4: Industry Development - Chengdu's biopharmaceutical industry is positioned for significant growth, with a focus on research and development, market expansion, and integration of medical and engineering sectors [7][8] - Recent policies aim to enhance the ecosystem for biopharmaceuticals, including financial incentives for innovative drug development [8][9]